Grail CFO Sells 7,900 Shares for $672,000
On August 27, 2026, Grail's Chief Financial Officer Aaron Freidin sold 7,900 shares of the company at a weighted average price of $85.01 per share, totaling approximately $672,000 in transaction value. The sale occurred on a day when the stock closed lower at $82.50. Despite this insider activity, Freidin still holds 253,083 shares directly after the transaction, representing roughly 0.5% ownership valued at around $20.9 million as of market close. Grail operates in the healthcare diagnostics sector and provides multi-cancer early detection testing services through its flagship product Galleri. The company reported trailing twelve months (TTM) revenue of $165.3 million but also recorded a net loss of $391.6 million during that period, reflecting ongoing financial challenges despite significant market valuation. The transaction is not seen as alarming for investors due to the relatively small size compared to Freidin's remaining holdings and his continued stake in Grail’s future performance.
Tickers: $GRAL
Topics: CFO sale of shares Grail SEC Form 4